Fatty liver in pregnancy: a narrative review of two distinct conditions

References

• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850.
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Milic N, Di Renzo L, et al. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22:7006–7016.
   PubMed Web of Science ®Google Scholar
• Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51:1781–1789.
   PubMed Web of Science ®Google Scholar
• Mazzotti A, Caletti MT, Sasdelli AS, et al. Pathophysiology of nonalcoholic fatty liver disease: lifestyle-gut-gene interaction. Dig Dis. 2016;34(Suppl 1):3–10.
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2:901–910.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Marchesini G. When the journey from obesity to cirrhosis takes an early start. J Hepatol. 2016;65:249–251.
   PubMed Web of Science ®Google Scholar
• Wieland A, Frank DN, Harnke B, et al. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015;42:1051–1063.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.
   PubMed Web of Science ®Google Scholar
• Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69:718–735.
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69:896–904.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64:1577–1586.
   PubMed Web of Science ®Google Scholar
• Italian Association for the Study of the Liver. AISF position paper on liver disease and pregnancy. Dig Liver Dis. 2016;48:120–137.
   PubMedGoogle Scholar
• Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793–801.
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64:933–945.
   PubMed Web of Science ®Google Scholar
• Garcia-Romero CS, Guzman C, Cervantes A, et al. Liver disease in pregnancy: medical aspects and their implications for mother and child. Ann Hepatol. 2019;18:553–562.
   PubMed Web of Science ®Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
   PubMed Web of Science ®Google Scholar
• Alese MO, Moodley J, Naicker T. Preeclampsia and HELLP syndrome, the role of the liver. J Matern Fetal Neonatal Med. 2019 Jan 31. (Epub ahead of print). DOI: 10.1080/14767058.2019.1572737.
   PubMedGoogle Scholar
• Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32–36.
   PubMed Web of Science ®Google Scholar
• Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–854.
   PubMed Web of Science ®Google Scholar
• Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology. 2008;47:455–460.
   PubMed Web of Science ®Google Scholar
• Hershman M, Mei R, Kushner T. Implications of nonalcoholic fatty liver disease on pregnancy and maternal and child outcomes. Gastroenterol Hepatol (NY). 2019;15:221–228.
   PubMedGoogle Scholar
• De Souza LR, Berger H, Retnakaran R, et al. Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy: prospective study. Am J Gastroenterol. 2016;111:665–670.
   PubMed Web of Science ®Google Scholar
• Hagstrom H, Hoijer J, Ludvigsson JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2016;36:268–274.
   PubMed Web of Science ®Google Scholar
• Yarrington CD, Cantonwine DE, Seely EW, et al. The association of alanine aminotransferase in early pregnancy with gestational diabetes. Metab Syndr Relat Disord. 2016;14:254–258.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kwak SH, Koo JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2019;62:238–248.
   PubMed Web of Science ®Google Scholar
• Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23:588S–95S.
   PubMed Web of Science ®Google Scholar
• Wesolowski SR, Kasmi KC, Jonscher KR, et al. Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2017;14:81–96.
   PubMed Web of Science ®Google Scholar
• Nobili V, Marcellini M, Marchesini G, et al. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007;30:2638–2640.
   PubMed Web of Science ®Google Scholar
• Bruce KD, Jonscher KR. Assessment of fatty liver in models of disease programming. Methods Mol Biol. 2018;1735:251–266.
   PubMedGoogle Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328–357.
   PubMed Web of Science ®Google Scholar
• Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367–78e5; quiz e14-5.
   PubMed Web of Science ®Google Scholar
• Wong VW, Wong GL, Chan RS, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol. 2018;69:1349–1356.
   PubMed Web of Science ®Google Scholar
• Itoh H, Kanayama N. Developmental origins of nonalcoholic fatty liver disease (NAFLD). Adv Exp Med Biol. 2018;1012:29–39.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2019;16:377–386.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S165–S72.
   PubMed Web of Science ®Google Scholar
• Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018;6:e000456.
   PubMed Web of Science ®Google Scholar
• Balsells M, Garcia-Patterson A, Sola I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102.
   PubMed Web of Science ®Google Scholar
• Farrar D, Simmonds M, Bryant M, et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017;7:e015557.
   PubMed Web of Science ®Google Scholar
• Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med. 2014;31:282–291.
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Gaunt P, Aithal GP, et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387:679–690.
   PubMed Web of Science ®Google Scholar
• Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112:838–846.
   PubMed Web of Science ®Google Scholar
• Farajpour R, Ghavidel A, Farajpour S, et al. A case of acute fatty liver of second trimester of pregnancy. Hepatol Int. 2015;2015:S389–90.
   Google Scholar
• Monga M, Katz AR. Acute fatty liver in the second trimester. Obstet Gynecol. 1999;93:811–813.
   PubMed Web of Science ®Google Scholar
• Buytaert IM, Elewaut GP, Van Kets HE. Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol. 1996;91:603–604.
   PubMed Web of Science ®Google Scholar
• de Nagy J, Strittmatter CA, Lee RV. Acute fatty liver of pregnancy presenting as hepatic encephalopathy at 28 weeks’ gestation. J Obstet Gynaecol. 2008;28:100–102.
   PubMedGoogle Scholar
• Suzuki S, Watanabe S, Araki T. Acute fatty liver of pregnancy at 23 weeks of gestation. BJOG. 2001;108:223–224.
   PubMedGoogle Scholar
• Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419.
   PubMed Web of Science ®Google Scholar
• Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57:951–956.
   PubMed Web of Science ®Google Scholar
• Ch’ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51:876–880.
   PubMed Web of Science ®Google Scholar
• Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209:456 e1–7.
   Web of Science ®Google Scholar
• Solanke D, Rathi C, Pandey V, et al. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: a prospective study from Western India. Indian J Gastroenterol. 2016;35:450–458.
   PubMed Web of Science ®Google Scholar
• Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389–395.
   PubMed Web of Science ®Google Scholar
• Liu G, Shang X, Yuan B, et al. Acute fatty liver of pregnancy: analysis on the diagnosis and treatment of 15 cases. J Reprod Med. 2016;61:282–286.
   PubMed Web of Science ®Google Scholar
• Natarajan SK, Ibdah JA. Role of 3-hydroxy fatty acid-induced hepatic lipotoxicity in acute fatty liver of pregnancy. Int J Mol Sci. 2018;19:322.
   Web of Science ®Google Scholar
• Brett KE, Ferraro ZM, Yockell-Lelievre J, et al. Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta. Int J Mol Sci. 2014;15:16153–16185.
   PubMed Web of Science ®Google Scholar
• Shekhawat P, Bennett MJ, Sadovsky Y, et al. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab. 2003;284:E1098–105.
   PubMed Web of Science ®Google Scholar
• Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? Gut. 2011;60:138–9; author reply 9–40
   PubMed Web of Science ®Google Scholar
• Castro MA, Ouzounian JG, Colletti PM, et al. Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med. 1996;41:839–843.
   PubMed Web of Science ®Google Scholar
• Wei Q, Zhang L, Liu X. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. J Obstet Gynaecol Res. 2010;36:751–756.
   PubMed Web of Science ®Google Scholar
• Cheng N, Xiang T, Wu X, et al. Acute fatty liver of pregnancy: a retrospective study of 32 cases in South China. J Matern Fetal Neonatal Med. 2014;27:1693–1697.
   PubMed Web of Science ®Google Scholar
• Goodacre RL, Hunter DJ, Millward S, et al. The diagnosis of acute fatty liver of pregnancy by computed tomography. J Clin Gastroenterol. 1988;10:680–682.
   PubMed Web of Science ®Google Scholar
• Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994;171:1342–1347.
   PubMed Web of Science ®Google Scholar
• Chatel P, Ronot M, Roux O, et al. Transient excess of liver fat detected by magnetic resonance imaging in women with acute fatty liver of pregnancy. Am J Obstet Gynecol. 2016;214:127–129.
   PubMed Web of Science ®Google Scholar
• Duvekot J, Verveer C, Neven L, et al. Transient elastography (TE) of the liver as a new diagnostic tool to discriminate between HELLP syndrome and acute fatty liver of pregnancy (AFLP)? Pregnancy Hypertens. 2015;5:2–3.
   Google Scholar
• Kushner T, Sarkar M, Tran T. Noninvasive tests for prognosticating outcomes in patients with chronic liver disease in pregnancy: ready for prime time? Am J Gastroenterol. 2019;114:209–211.
   PubMed Web of Science ®Google Scholar
• Jayawardena L, McNamara E. Diagnosis and management of pregnancies complicated by Haemolysis, Elevated Liver Enzymes and Low Platelets (HELLP) syndrome in the tertiary setting. Intern Med J. 2019 May 6. (Epub ahead of print). DOI: 10.1111/imj.14337.
   PubMedGoogle Scholar
• Vigil-De Gracia P. Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders. Int J Gynaecol Obstet. 2001;73:215–220.
   PubMed Web of Science ®Google Scholar
• Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.
   PubMed Web of Science ®Google Scholar
• Minakami H, Morikawa M, Yamada T, et al. Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts. J Obstet Gynaecol Res. 2014;40:641–649.
   PubMed Web of Science ®Google Scholar
• Morton A. Acute fatty liver of pregnancy-differential diagnosis. Am J Gastroenterol. 2017;112:1342.
   PubMed Web of Science ®Google Scholar
• Hay JE. Liver disease in pregnancy. Hepatology. 2008;47:1067–1076.
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang P, Gong Y, et al. Treating acute fatty liver of pregnancy with artificial liver support therapy: systematic review. Medicine (Baltimore). 2018;97:e12473.
   PubMed Web of Science ®Google Scholar
• Kushner T, Tholey D, Dodge J, et al. Outcomes of liver transplantation for acute fatty liver disease of pregnancy. Am J Transplant. 2019;19:2101–2107.
   PubMed Web of Science ®Google Scholar
• Li P, Lin S, Li L, et al. Utility of MELD scoring system for assessing the prognosis of acute fatty liver of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019;240:161–166.
   PubMed Web of Science ®Google Scholar
• Yang Y, Deng L, Li X, et al. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012;31:2673–2678.
   PubMed Web of Science ®Google Scholar
• Murali AR, Devarbhavi H, Venkatachala PR, et al. Factors that predict 1-month mortality in patients with pregnancy-specific liver disease. Clin Gastroenterol Hepatol. 2014;12:109–113.
   PubMed Web of Science ®Google Scholar
• Wei Y, Xu Q, Yang H, et al. Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: a population-based cohort study in China. PLoS Med. 2019;16:e1002926.
   PubMed Web of Science ®Google Scholar
• Gonsalkorala ES, Cannon MD, Lim TY, et al. Non-invasive markers (ALBI and APRI) predict pregnancy outcomes in women with chronic liver disease. Am J Gastroenterol. 2019;114:267–275.
   PubMed Web of Science ®Google Scholar
• Hadem J, Stiefel P, Bahr MJ, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339–345.
   PubMedGoogle Scholar
• Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant. 2010;10:2520–2526.
   PubMed Web of Science ®Google Scholar
• Cetin O, Karaman E, Arslan H, et al. Evaluation of maternal liver elasticity by acoustic radiation force impulse elastosonography in hypertensive disorders of pregnancy: a preliminary descriptive study. J Matern Fetal Neonatal Med. 2017;30:2281–2286.
   PubMed Web of Science ®Google Scholar
• Pavlides M, Banerjee R, Tunnicliffe EM, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017;37:1065–1073.
   PubMed Web of Science ®Google Scholar
• Wilman HR, Kelly M, McDonald N, et al. Non-invasive multiparametric MRI (LiverMultiScanTM) effectively excludes NASH and liver fibrosis in at risk patients. J Hepatol. 2017;66:S242.
   PubMed Web of Science ®Google Scholar